StackGuide
← The Stack
IV Supplements Maybe

Vitamin D: correct a deficiency, don't chase a supplement

Worth taking if you're actually low; largely inert for hard outcomes if you're already replete. A fix for a deficiency, not a longevity lever.

5 min read · Reviewed July 2, 2026 · For: People with low levels, limited sun, darker skin at high latitudes, or malabsorption. Not everyone, and not at heroic doses.

The quick answer

In a large trial of generally replete adults, 2000 IU/day didn't reduce cancer or cardiovascular disease. Vitamin D matters when you're deficient — correct that. If your level is fine, more is not better, and high-dose megadosing carries its own small risks.

Vitamin D is where a real biological necessity got stretched into a cure-all. The nutrient genuinely matters — bone, immune function, muscle — and true deficiency is worth correcting. The overreach was assuming that if some is essential, more must be protective for everyone.

The trials say otherwise. VITAL gave roughly 26,000 mostly-replete adults 2000 IU/day and found no reduction in cancer or cardiovascular events. The NIH’s own review lands in the same place: for people who are already sufficient, supplementing doesn’t move the hard outcomes. That’s the crucial distinction the supplement aisle blurs — replete versus deficient are two different situations.

The sensible version

If you have reason to be low — little sun, higher latitude, darker skin, malabsorption, or a symptomatic picture — test and correct it, and modest daily dosing does that well and cheaply. If your level is fine, adding more doesn’t buy you longevity, and very high doses carry their own small risks (calcium handling). This is a targeted fix wearing the costume of a universal one, which is why it sits low in the supplement tier: real when it applies, inert when it doesn’t.

Evidence, by outcome

Each claim carries its own grade. A strong grade on one outcome doesn't launder a weak one — read them separately.

Cancer & cardiovascular disease No effect A Strong

In a generally vitamin-D-replete population, 2000 IU/day did not lower invasive cancer or major cardiovascular events. 1

VITAL, ~26,000 people. A clean null for supplementing people who aren't deficient — which is the situation most supplement-buyers are actually in.

General supplementation No effect B Moderate

Trials generally do not support vitamin D supplementation to reduce cardiovascular disease or cancer in people who are already sufficient. 2

How to buy it well

Over the counter
Buy

Vitamin D3 (cholecalciferol) softgels, dosed to your tested need — commonly 1000–2000 IU.

Dose 1000–2000 IU/day (if tested low) Typical price ~$0.02–0.08 per softgel
Look for
  • D3 rather than D2, with IU per softgel clearly stated
  • USP Verified single-ingredient product
Skip / avoid
  • Heroic 10,000+ IU daily megadoses taken without a blood test
  • Paying a premium for 'liposomal' or exotic delivery — plain D3 is well absorbed
Certifications worth paying for
USP Verified
Where — legitimate options
  • Costco / Amazon / big-box pharmacies Retailer D3 is a commodity; cheapest per IU is fine — a USP mark is a bonus, not a necessity.
  • NOW Foods / Nature Made Brand Reliable low-cost D3; Nature Made carries USP-verified lines.

StackGuide sells nothing and links to no seller. Vendors are named for orientation, not endorsement; prices are typical ranges, not quotes.

Sources

  1. 1
    Randomized trial

    Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease (VITAL)

    New England Journal of Medicine, 2019

    Read the source pubmed.ncbi.nlm.nih.gov
  2. 2
    Guideline / consensus

    Vitamin D: Fact Sheet for Health Professionals

    NIH Office of Dietary Supplements

    Read the source ods.od.nih.gov